Technology
Ultra Clean Reports Third Quarter 2024 Financial Results
Published
2 years agoon
By
HAYWARD, Calif., Oct. 28, 2024 /PRNewswire/ — Ultra Clean Holdings, Inc. (Nasdaq: UCTT), today reported its financial results for the third quarter ended September 27, 2024.
“UCT’s third quarter results came in above expectations driven by broader equipment demand for AI infrastructure build out and sustained domestic China market spending,” said Jim Scholhamer, CEO. “The rationale for significant long-term investment in WFE remains strong. UCT’s vertical integration capabilities and strategic manufacturing network provide a competitive edge, and should enable us to increase share as demand expands.”
Third Quarter 2024 GAAP Financial Results
Total revenue was $540.4 million. Products contributed $479.0 million and Services added $61.4 million. Total gross margin was 17.3%, operating margin was 4.7%, and net loss was $(2.3) million or $(0.05) per diluted share. This compares to total revenue of $516.1 million, gross margin of 17.1%, operating margin of 4.4%, and net income of $19.1 million or $0.42 per diluted share, in the prior quarter.
Third Quarter 2024 Non-GAAP Financial Results
On a non-GAAP basis, gross margin was 17.8%, operating margin was 7.3%, and net income was $15.9 million or $0.35 per diluted share. This compares to gross margin of 17.7%, operating margin of 6.9%, and net income of $14.4 million or $0.32 per diluted share in the prior quarter.
Fourth Quarter 2024 Outlook
The Company expects revenue in the range of $535 million to $585 million. The Company expects GAAP diluted net income per share to be between $0.06 and $0.26 and non-GAAP diluted net income per share to be between $0.34 and $0.54.
Conference Call
The conference call and webcast will take place on Monday, October 28, 2024 at 1:45 p.m. PT and can be accessed by dialing 1-800-836-8184 or 1-646-357-8785. No passcode is required. A replay of the call will be available by dialing 1-888-660-6345 or 1-646-517-4150 and entering the confirmation code 34185#. The Webcast will be available on the Investor Relations section of the Company’s website at http://uct.com/investors/events/.
About Ultra Clean Holdings, Inc.
Ultra Clean Holdings, Inc. is a leading developer and supplier of critical subsystems, components, parts, and ultra-high purity cleaning and analytical services, primarily for the semiconductor industry. Under its Products division, UCT offers its customers an integrated outsourced solution for major subassemblies, improved design-to-delivery cycle times, design for manufacturability, prototyping, and high-precision manufacturing. Under its Services Division, UCT offers its customers tool chamber parts cleaning and coating, as well as micro-contamination analytical services. Ultra Clean is headquartered in Hayward, California. Additional information is available at www.uct.com.
Use of Non-GAAP Measures
In addition to providing results that are determined in accordance with Generally Accepted Accounting Principles in the United States of America (“GAAP”), management uses non-GAAP gross margin, non-GAAP operating margin and non-GAAP net income to evaluate the Company’s operating and financial results. We believe the presentation of non-GAAP results is useful to investors for analyzing our core business and business trends and comparing performance to prior periods, along with enhancing investors’ ability to view the Company’s results from management’s perspective. The presentation of this additional information should not be considered a substitute for results prepared in accordance with GAAP. Tables presenting reconciliations from GAAP results to non-GAAP results are included at the end of this press release.
The Company defines non-GAAP net income as net income (loss) before amortization of intangible assets, stock-based compensation, restructuring charges, acquisition activity costs, fair value adjustments, debt refinancing costs, legal-related costs and the tax effects of the foregoing adjustments.
A reconciliation of our guidance for non-GAAP net income per diluted share for the subsequent quarter is not available due to fluctuations in the geographic mix of our earnings from quarter to quarter, which impacts our tax rate and cannot be reasonably predicted or determined. As a result, such reconciliation is not available without unreasonable efforts and we are unable to determine the probable significance of the unavailable information.
Safe Harbor Statement
The foregoing information contains, or may be deemed to contain, “forward-looking statements” (as defined in the US Private Securities Litigation Reform Act of 1995) which reflect our current views with respect to future events and financial performance. We use words such as “anticipates,” “projection,” “outlook,” “forecast,” “believes,” “plan,” “expect,” “future,” “intends,” “may,” “will,” “estimates,” “see,” “predicts,” “should” and similar expressions to identify these forward-looking statements. Forward looking statements included in this press release include our expectations about the semiconductor capital equipment market and outlook. All forward-looking statements address matters that involve risks and uncertainties. Accordingly, the Company’s actual results may differ materially from the results predicted or implied by these forward-looking statements. These risks, uncertainties and other factors also include, among others, those identified in “Risk Factors,” “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and elsewhere in our annual report on Form 10-K for the year ended December 29, 2023, as filed with the Securities and Exchange Commission. Ultra Clean Holdings, Inc. undertakes no obligation to publicly update or review any forward-looking statements, whether as a result of new information, future developments or otherwise unless required by law.
Contact:
Rhonda Bennetto
SVP Investor Relations
rbennetto@uct.com
ULTRA CLEAN HOLDINGS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(Unaudited; in millions, except per share data)
Three Months Ended
Nine Months Ended
September 27,
2024
September 29,
2023
September 27,
2024
September 29,
2023
Revenues:
Product
$ 479.0
$ 380.9
$ 1,350.2
$ 1,112.0
Services
61.4
54.1
184.1
177.8
Total revenues
540.4
435.0
1,534.3
1,289.8
Cost of revenues:
Product
403.3
329.3
1,141.2
955.5
Services
43.7
40.5
128.6
128.0
Total cost revenues
447.0
369.8
1,269.8
1,083.5
Gross margin
93.4
65.2
264.5
206.3
Operating expenses:
Research and development
7.1
7.4
21.2
21.7
Sales and marketing
14.4
12.8
42.9
38.6
General and administrative
46.7
39.3
135.1
115.3
Total operating expenses
68.2
59.5
199.2
175.6
Income from operations
25.2
5.7
65.3
30.7
Interest income
1.1
1.2
3.9
2.5
Interest expense
(12.0)
(12.3)
(35.8)
(35.9)
Other income (expense), net
(4.1)
(2.1)
9.3
(0.8)
Income before provision for income taxes
10.2
(7.5)
42.7
(3.5)
Provision for income taxes
9.9
5.3
28.2
17.1
Net income (loss)
0.3
(12.8)
14.5
(20.6)
Less: Net income attributable to noncontrolling interests
2.6
1.7
7.1
6.7
Net income (loss) attributable to UCT
$ (2.3)
$ (14.5)
$ 7.4
$ (27.3)
Net income (loss) per share attributable to UCT common stockholders:
Basic
$ (0.05)
$ (0.32)
$ 0.16
$ (0.61)
Diluted
$ (0.05)
$ (0.32)
$ 0.16
$ (0.61)
Shares used in computing net income (loss) per share:
Basic
45.0
44.8
44.8
44.8
Diluted
45.0
44.8
45.4
44.8
ULTRA CLEAN HOLDINGS, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(Unaudited; in millions)
September 27,
2024
December 29,
2023
ASSETS
Current assets:
Cash and cash equivalents
$ 318.2
$ 307.0
Accounts receivable, net of allowance for credit losses
228.1
180.8
Inventories
402.6
374.5
Prepaid expenses and other current assets
36.9
30.9
Total current assets
985.8
893.2
Property, plant and equipment, net
327.7
328.3
Goodwill
265.3
265.2
Intangible assets, net
192.4
215.3
Deferred tax assets, net
3.6
3.1
Operating lease right-of-use assets
162.2
151.7
Other non-current assets
10.5
10.9
Total assets
$ 1,947.5
$ 1,867.7
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Bank borrowings
$ 16.4
$ 17.6
Accounts payable
233.2
192.9
Accrued compensation and related benefits
47.9
47.7
Operating lease liabilities
19.0
18.1
Other current liabilities
42.3
33.7
Total current liabilities
358.8
310.0
Bank borrowings, net of current portion
475.8
461.2
Deferred tax liabilities
18.9
19.0
Operating lease liabilities
155.6
143.0
Other liabilities
16.0
37.3
Total liabilities
1,025.1
970.5
Equity:
UCT stockholders’ equity:
Common stock
507.7
496.6
Retained earnings
354.1
346.7
Accumulated other comprehensive loss
(3.9)
(4.4)
Total UCT stockholders’ equity
857.9
838.9
Noncontrolling interests
64.5
58.3
Total equity
922.4
897.2
Total liabilities and equity
$ 1,947.5
$ 1,867.7
ULTRA CLEAN HOLDINGS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited; in millions)
Nine Months Ended
September 27,
2024
September 29,
2023
Cash flows from operating activities:
Net income (loss)
$ 14.5
$ (20.6)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation and amortization
34.1
27.9
Amortization of intangible assets
22.9
16.9
Stock-based compensation
12.7
8.7
Amortization of debt issuance costs
2.4
2.9
Change in the fair value of financial instruments
(21.7)
(0.3)
Deferred income taxes
(1.2)
0.1
Loss (gain) on sale of property, plant and equipment
1.2
(1.1)
Changes in assets and liabilities:
Accounts receivable
(47.3)
83.2
Inventories
(28.1)
65.6
Prepaid expenses and other current assets
(2.9)
7.5
Other non-current assets
0.6
0.8
Accounts payable
46.1
(61.2)
Accrued compensation and related benefits
0.2
(11.8)
Income taxes payable
1.4
(8.9)
Operating lease assets and liabilities
8.1
(3.7)
Other liabilities
4.9
(5.4)
Net cash provided by operating activities
47.9
100.6
Cash flows from investing activities:
Purchases of property, plant and equipment
(46.2)
(59.2)
Proceeds from sale of equipment
—
2.3
Net cash used in investing activities
(46.2)
(56.9)
Cash flows from financing activities:
Proceeds from bank borrowings
67.7
—
Proceeds from issuance of common stock
0.9
—
Extinguishment of debt
(44.2)
—
Principal payments on bank borrowings
(10.1)
(34.7)
Payment of debt issuance costs
(2.5)
(0.3)
Employees’ taxes paid upon vesting of restricted stock units
(2.5)
(2.2)
Payments of dividends to a joint venture shareholder
(0.5)
(0.1)
Repurchase of shares
—
(23.7)
Net cash provided by (used in) financing activities
8.8
(61.0)
Effect of exchange rate changes on cash and cash equivalents
0.7
0.5
Net increase (decrease) in cash and cash equivalents
11.2
(16.8)
Cash and cash equivalents at beginning of period
307.0
358.8
Cash and cash equivalents at end of period
$ 318.2
$ 342.0
ULTRA CLEAN HOLDINGS, INC.
REPORTABLE SEGMENTS
GAAP TO NON-GAAP RECONCILIATION
(Unaudited; dollars in millions)
GAAP
Non-GAAP
Three Months Ended
Three Months Ended
September 27, 2024
September 27, 2024
Products
Services
Consolidated
Products
Services
Consolidated
Revenues
$ 479.0
$ 61.4
$ 540.4
$ 479.0
$ 61.4
$ 540.4
Gross profit
$ 75.7
$ 17.7
$ 93.4
$ 77.3
$ 18.7
$ 96.0
Gross margin
15.8 %
28.8 %
17.3 %
16.1 %
30.5 %
17.8 %
Income from operations
$ 22.4
$ 2.8
$ 25.2
$ 33.3
$ 6.2
$ 39.5
Operating margin
4.7 %
4.6 %
4.7 %
7.0 %
10.1 %
7.3 %
Three Months Ended
September 27, 2024
Products
Services
Consolidated
Reconciliation of GAAP Gross profit to Non-GAAP Gross profit (in millions)
Reported gross profit on a GAAP basis
$ 75.7
$ 17.7
$ 93.4
Amortization of intangible assets (1)
1.3
1.0
2.3
Stock-based compensation expense (2)
0.3
—
0.3
Non-GAAP gross profit
$ 77.3
$ 18.7
$ 96.0
Reconciliation of GAAP Gross margin to Non-GAAP Gross margin
Reported gross margin on a GAAP basis
15.8 %
28.8 %
17.3 %
Amortization of intangible assets (1)
0.2 %
1.7 %
0.4 %
Stock-based compensation expense (2)
0.1 %
— %
0.1 %
Non-GAAP gross margin
16.1 %
30.5 %
17.8 %
Reconciliation of GAAP Income from operations to Non-GAAP Income from operations (in millions)
Reported income from operations on a GAAP basis
$ 22.4
$ 2.8
$ 25.2
Amortization of intangible assets (1)
4.7
2.9
7.6
Stock-based compensation expense (2)
4.0
0.5
4.5
Restructuring charges (3)
0.3
—
0.3
Acquisition related costs (4)
0.6
—
0.6
Legal-related costs (5)
1.3
—
1.3
Non-GAAP income from operations
$ 33.3
$ 6.2
$ 39.5
Reconciliation of GAAP Operating margin to Non-GAAP Operating margin
Reported operating margin on a GAAP basis
4.7 %
4.6 %
4.7 %
Amortization of intangible assets (1)
1.0 %
4.7 %
1.4 %
Stock-based compensation expense (2)
0.8 %
0.8 %
0.8 %
Restructuring charges (3)
0.1 %
— %
0.1 %
Acquisition related costs (4)
0.1 %
— %
0.1 %
Legal-related costs (5)
0.3 %
— %
0.2 %
Non-GAAP operating margin
7.0 %
10.1 %
7.3 %
1 Amortization of intangible assets related to the Company’s business acquisitions
2 Represents compensation expense for stock granted to employees and directors
3 Represents severance, retention and costs related to facility closures
4 Represents acquisition activity costs
5 Represents estimated costs related to certain legal proceedings
ULTRA CLEAN HOLDINGS, INC.
UNAUDITED RECONCILIATION OF GAAP TO NON-GAAP ADJUSTED RESULTS
Three Months Ended
September 27,
2024
September 29,
2023
June 28,
2024
Reconciliation of GAAP Net Income (Loss) to Non-GAAP Net Income (in millions)
Reported net income (loss) attributable to UCT on a GAAP basis
(2.3)
$ (14.5)
$ 19.1
Amortization of intangible assets (1)
7.6
5.5
7.6
Stock-based compensation expense (2)
4.5
3.9
4.7
Restructuring charges (3)
0.3
3.2
0.5
Acquisition related costs (4)
0.6
0.7
—
Fair value related adjustments (5)
0.8
—
(24.1)
Debt refinancing costs expensed (6)
—
—
3.6
Legal-related costs (7)
1.3
—
—
Income tax effect of non-GAAP adjustments (8)
(4.1)
(5.0)
1.9
Income tax effect of valuation allowance (9)
7.2
8.2
1.1
Non-GAAP net income attributable to UCT
$ 15.9
$ 2.0
$ 14.4
Reconciliation of GAAP Income from operations to Non-GAAP Income from operations (in millions)
Reported income from operations on a GAAP basis
$ 25.2
$ 5.7
$ 22.9
Amortization of intangible assets (1)
7.6
5.5
7.6
Stock-based compensation expense (2)
4.5
3.9
4.7
Restructuring charges (3)
0.3
3.2
0.5
Acquisition related costs (4)
0.6
0.7
—
Legal-related costs (7)
1.3
—
—
Non-GAAP income from operations
$ 39.5
$ 19.0
$ 35.7
Reconciliation of GAAP Operating margin to Non-GAAP Operating margin
Reported operating margin on a GAAP basis
4.7 %
1.3 %
4.4 %
Amortization of intangible assets (1)
1.4 %
1.3 %
1.5 %
Stock-based compensation expense (2)
0.8 %
0.9 %
0.9 %
Restructuring charges (3)
0.1 %
0.7 %
0.1 %
Acquisition related costs (4)
0.1 %
0.2 %
— %
Legal-related costs (7)
0.2 %
— %
— %
Non-GAAP operating margin
7.3 %
4.4 %
6.9 %
Reconciliation of GAAP Gross profit to Non-GAAP Gross profit (in millions)
Reported gross profit on a GAAP basis
$ 93.4
$ 65.2
$ 88.5
Amortization of intangible assets (1)
2.3
1.5
2.3
Stock-based compensation expense (2)
0.3
0.2
0.5
Restructuring charges (3)
—
0.7
0.2
Non-GAAP gross profit
$ 96.0
$ 67.6
$ 91.5
Reconciliation of GAAP Gross margin to Non-GAAP Gross margin
Reported gross margin on a GAAP basis
17.3 %
15.0 %
17.1 %
Amortization of intangible assets (1)
0.4 %
0.3 %
0.5 %
Stock-based compensation expense (2)
0.1 %
0.0 %
0.1 %
Restructuring charges (3)
— %
0.2 %
0.0 %
Non-GAAP gross margin
17.8 %
15.5 %
17.7 %
Reconciliation of GAAP Other income (expense), net to Non-GAAP Other income (expense), net (in millions)
Reported Other income (expense), net on a GAAP basis
$ (4.1)
$ (2.1)
$ 17.4
Fair value related adjustments (5)
0.8
—
(24.1)
Debt refinancing costs expensed (6)
—
—
3.6
Non-GAAP Other income (expense), net
$ (3.3)
$ (2.1)
$ (3.1)
Reconciliation of GAAP Income (Loss) Per Diluted Share to Non-GAAP Earnings Per Diluted Share
Reported net income (loss) on a GAAP basis
$ (0.05)
$ (0.32)
$ 0.42
Amortization of intangible assets (1)
0.17
0.12
0.17
Stock-based compensation expense (2)
0.10
0.09
0.10
Restructuring charges (3)
0.00
0.07
0.01
Acquisition related costs (4)
0.01
0.02
—
Fair value related adjustments (5)
0.02
—
(0.53)
Debt refinancing costs expensed (6)
—
—
0.08
Legal-related costs (7)
0.03
—
—
Income tax effect of non-GAAP adjustments (8)
(0.09)
(0.11)
0.04
Income tax effect of valuation allowance (9)
0.16
0.17
0.03
Non-GAAP net earnings
$ 0.35
$ 0.04
$ 0.32
Weighted average number of diluted shares (in millions) on a non-GAAP basis
45.5
45.0
45.4
ULTRA CLEAN HOLDINGS, INC.
UNAUDITED RECONCILIATION OF GAAP TO NON-GAAP EFFECTIVE INCOME TAX RATE
Three Months Ended
September 27,
2024
September 29,
2023
June 28,
2024
Provision for income taxes on a GAAP basis
$ 9.9
$ 5.3
$ 8.5
Income tax effect of non-GAAP adjustments (8)
4.1
5.0
(1.9)
Income tax effect of valuation allowance (9)
(7.2)
(8.2)
(1.1)
Non-GAAP provision for income taxes
$ 6.8
$ 2.2
$ 5.5
Income before income taxes on a GAAP basis
$ 10.2
$ (7.5)
$ 30.0
Amortization of intangible assets (1)
7.6
5.5
7.6
Stock-based compensation expense (2)
4.5
3.9
4.7
Restructuring charges (3)
0.3
3.2
0.5
Acquisition related costs (4)
0.6
0.7
—
Fair value related adjustments (5)
0.8
—
(24.1)
Debt refinancing costs expensed (6)
—
—
3.6
Legal-related costs (7)
1.3
—
—
Non-GAAP income before income taxes
$ 25.3
$ 5.8
$ 22.3
Effective income tax rate on a GAAP basis
97.1 %
(70.7) %
28.3 %
Non-GAAP effective income tax rate
27.1 %
37.3 %
24.7 %
1 Amortization of intangible assets related to the Company’s business acquisitions
2 Represents compensation expense for stock granted to employees and directors
3 Represents severance, retention and costs related to facility closures
4 Represents acquisition activity costs
5 Fair value adjustments related to contingent consideration
6 Represents the third party transaction costs related to the amended credit agreement and the previously capitalized
costs of extinguished debt
7 Represents estimated costs related to certain legal proceedings
8 Tax effect of items (1) through (7) above based on the non-GAAP tax rate
9 The Company’s GAAP tax expense is generally higher than the Company’s non-GAAP tax expense, primarily due to
losses in the U.S. with full federal and state valuation allowances. The Company’s non-GAAP tax rate and resulting
non-GAAP tax expense considers the tax implications as if there was no federal or state valuation allowance position
in effect
View original content to download multimedia:https://www.prnewswire.com/news-releases/ultra-clean-reports-third-quarter-2024-financial-results-302288868.html
SOURCE Ultra Clean Holdings, Inc.
You may like
Technology
HelloNation Article Highlights Sterile Compounding and Medication Safety With Insights From Compounding Pharmacist Expert Laura Temple
Published
44 minutes agoon
July 21, 2026By
The article explains how sterile compounded medications are prepared to reduce the risk of contamination and support safe, customized treatments.
AZLE, Texas, July 21, 2026 /PRNewswire/ — What does sterile compounding mean for medication safety? HelloNation has published an article explaining how sterile compounding helps pharmacies prepare highly specialized medications while adhering to strict contamination-prevention procedures.
The article features insights from Laura Temple, Compounding Pharmacist Expert and Owner of Laura’s Pharmacy in Azle, Texas. It explains that sterile compounding is a specialized process for preparing medications in carefully controlled environments designed to reduce the risk of contamination. Sterile compounded medications are often used for injections, eye drops, IV medications, and other therapies that require the highest levels of cleanliness and precision.
The HelloNation article explains that sterile compounded medications differ from commercially manufactured drugs because they are prepared individually for a patient’s unique medical needs. Physicians may prescribe compounded prescriptions when a patient requires a customized dosage, a combination medication, or a treatment not commercially available. Because these medications often bypass the body’s natural defenses, medication safety depends on strict preparation standards throughout the compounding process.
The article describes how pharmacies that provide sterile compounding rely on cleanroom environments equipped with filtered-air systems, specialized equipment, and contamination-prevention protocols. Pharmacists and technicians follow detailed gowning, sterilization, and handwashing procedures before handling medication ingredients. These measures are designed to support medication safety by limiting exposure to bacteria, particles, and other contaminants.
According to the article, environmental monitoring also plays a critical role in sterile compounding. Temperature control, air quality testing, and routine equipment inspections help maintain consistent preparation standards. The article notes that sterile compounded medications may undergo additional quality assurance checks before being dispensed to patients. These procedures help support both treatment effectiveness and patient safety.
The HelloNation article also explains that pharmacies performing sterile compounding are expected to follow USP guidelines established for sterile preparation. These USP guidelines outline requirements for cleanroom pharmacy operations, environmental testing, employee training, and quality assurance practices. The article emphasizes that maintaining compliance with USP guidelines helps reinforce contamination prevention and consistent preparation standards for compounded prescriptions.
Patients seeking sterile compounded medications may also look for pharmacies that participate in accreditation programs or are overseen by state boards. The article explains that these programs review safety procedures, documentation practices, and facility standards to help maintain medication safety. Regular environmental monitoring and staff competency evaluations are also identified as important safeguards in sterile compounding operations.
The article further explains that communication between pharmacists, healthcare providers, and patients remains an important part of safe compounded prescriptions. Compounding pharmacists review prescriptions carefully, confirm dosing instructions, and evaluate ingredient compatibility before preparation begins. This collaborative approach supports medication safety by reducing the risk of errors and ensuring treatments meet individual patient needs.
The article concludes that sterile compounding continues to play an important role in healthcare, particularly for patients requiring customized therapies that are unavailable through traditional manufacturing channels. Whether preparing IV medications, injectable therapies, or other sterile compounded medications, pharmacies rely on contamination prevention procedures and strict preparation standards to support patient care. The article notes that understanding how sterile compounding works can help patients feel more informed about the safety measures involved in preparing specialized medications.
What Sterile Compounding Means for Medication Safety features insights from Laura Temple, a compounding pharmacist expert at Laura’s Pharmacy in Azle, Texas, on HelloNation.
About HelloNation
HelloNation is America’s Good News Network, a premier media platform built on the idea that good news travels faster when real people tell real stories. Through its community-focused publications and innovative “edvertising” approach, HelloNation delivers content that informs, inspires, and spotlights the leaders making a meaningful impact in their communities.
View original content to download multimedia:https://www.prnewswire.com/news-releases/hellonation-article-highlights-sterile-compounding-and-medication-safety-with-insights-from-compounding-pharmacist-expert-laura-temple-302831275.html
SOURCE HelloNation
Technology
CIOs Forced to Rethink Manual Compliance Processes as Regulatory Complexity Rises, Says Info-Tech Research Group
Published
44 minutes agoon
July 21, 2026By
Regulatory demands are increasing in volume, complexity, and speed, leaving many organizations reliant on fragmented, manual approaches that slow response times and increase risk. New insights from Info-Tech Research Group show that organizations need to adopt more structured and scalable approaches to keep pace with regulatory change. The firm’s recently published blueprint, Build a Regulatory IT Response Engine, provides frameworks, tools, and step-by-step guidance to help organizations translate regulatory requirements into actionable IT controls and prioritized initiatives.
ARLINGTON, Va., July 21, 2026 /PRNewswire/ — Growing regulatory pressure across jurisdictions is forcing organizations to rethink how they interpret, prioritize, and execute compliance requirements. Many IT teams continue to operate with inconsistent processes and limited coordination, resulting in delayed initiatives and increased exposure to financial and reputational risk. Info-Tech’s blueprint, Build a Regulatory IT Response Engine, introduces a coordinated and repeatable approach to help IT leaders operationalize compliance and improve execution outcomes.
Info-Tech’s findings indicate that while organizations recognize the need for faster and more consistent regulatory response, they continue to face barriers such as fragmented interpretation of requirements, weak prioritization, and limited scalability. AI-enabled tools can help streamline analysis and accelerate response planning, but without a coordinated approach grounded in governance and human oversight, those benefits are difficult to realize.
“Regulatory response is becoming too complex to manage through disconnected, manual processes,” says Ahmad Jowhar, senior research analyst at Info-Tech Research Group. “IT leaders need a repeatable way to interpret requirements, prioritize action, and use AI to accelerate planning without losing the governance and oversight needed to execute effectively.”
Key Challenges IT Leaders Face in Regulatory Response
Despite ongoing investments in compliance, organizations continue to face systemic challenges that hinder effective execution. Info-Tech’s blueprint highlights several areas where IT and compliance leaders struggle most:
Fragmented and manual processes that slow regulatory interpretation and response.Inconsistent application of regulatory requirements across teams and jurisdictions.Poor prioritization of IT initiatives, leading to missed deadlines and duplicated effort.Limited scalability to manage increasing regulatory volume and complexity.Misalignment between compliance activities and broader business priorities.
Info-Tech’s Framework for Building a Regulatory IT Response Engine
To address these challenges, Info-Tech recommends a structured, AI-enabled approach that improves consistency, speed, and scalability. The firm’s Build a Regulatory IT Response Engine blueprint outlines the following key priorities for IT leaders:
Define the regulatory landscape: Establish organizational context, governance structures, and a centralized inventory of applicable regulations.Translate requirements into IT controls: Use AI-enabled analysis and structured assessments to convert regulatory obligations into actionable controls.Prioritize IT initiatives: Align initiatives based on cost, effort, impact, and regulatory timelines to reduce execution risk.Build and communicate a roadmap: Develop a clear, resource-aligned roadmap to guide execution and stakeholder alignment.Establish a repeatable process: Continuously monitor, adapt, and refine regulatory response capabilities to maintain compliance over time.
Organizations that adopt this structured approach can move from reactive compliance efforts to a more proactive and scalable model that shortens response timelines, reduces manual effort, and strengthens execution.
The firm’s Build a Regulatory IT Response Engine blueprint includes practical tools such as a Regulation Inventory Tool, a Regulatory Response IT Action Plan Tool, a Communication Deck Template, and a Compliance Program Framework. By applying these resources, IT leaders can standardize regulatory responses, improve prioritization, and help ensure compliance initiatives are executed on time and in alignment with business priorities.
For exclusive and timely commentary from Info-Tech’s experts, including Ahmad Jowhar, and access to the complete Build a Regulatory IT Response Engine blueprint, please contact pr@infotech.com.
About Info-Tech Research Group
Info-Tech Research Group is the “get things done” partner for over 30,000 IT, HR, and marketing leaders worldwide. The fastest growing research and advisory firm, Info-Tech enables leaders to make well-informed decisions and transform their organizations through AI, strategic foresight, step-by-step methodologies, practical tools, industry-leading advisory, and training programs. For nearly 30 years, tens of thousands of private and public organizations have trusted Info-Tech to lead their most important initiatives through periods of change and deliver outcomes that truly matter.
To learn more about Info-Tech’s HR research and advisory services, visit McLean & Company, and for data-driven software buying insights and vendor evaluations, visit the firm’s SoftwareReviews platform.
Media professionals can register for unrestricted access to research across IT, HR, and software and hundreds of industry analysts through the firm’s Media Insiders program. To gain access, contact pr@infotech.com.
For information about Info-Tech Research Group or to access the latest research, visit infotech.com and connect via LinkedIn and X.
View original content to download multimedia:https://www.prnewswire.com/news-releases/cios-forced-to-rethink-manual-compliance-processes-as-regulatory-complexity-rises-says-info-tech-research-group-302831286.html
SOURCE Info-Tech Research Group
Technology
Atomera to Announce Second Quarter 2026 Financial Results and Host Webinar on Tuesday, August 4, 2026
Published
44 minutes agoon
July 21, 2026By
LOS GATOS, Calif., July 21, 2026 /PRNewswire/ — Atomera Incorporated (NASDAQ: ATOM), a semiconductor materials and technology licensing company, announced today that it plans to release its second quarter 2026 financial results after the market closes on Tuesday, Aug. 4, 2026.
The company will host a live video Zoom webinar at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) on Tuesday, Aug. 4, 2026, to discuss the results. The live webinar can be accessed through Atomera’s investor relations website at https://ir.atomera.com. A replay of the webcast will be available for 12 months. To pre-register for the webinar, use the following link.
https://atomera.zoom.us/webinar/register/WN_OJFbTWe1SIyV69LLdDadCw
About Atomera
Atomera Incorporated is a semiconductor materials and technology licensing company focused on deploying its proprietary, silicon-proven technology into the semiconductor industry. Atomera has developed Mears Silicon Technology™ (MST®), which increases performance and power efficiency in semiconductor transistors. MST can be implemented using equipment already deployed in semiconductor manufacturing facilities and is complementary to other nano-scaling technologies already in the semiconductor industry roadmap. More information can be found at www.atomera.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/atomera-to-announce-second-quarter-2026-financial-results-and-host-webinar-on-tuesday-august-4-2026-302830602.html
SOURCE Atomera Incorporated
HelloNation Article Highlights Sterile Compounding and Medication Safety With Insights From Compounding Pharmacist Expert Laura Temple
CIOs Forced to Rethink Manual Compliance Processes as Regulatory Complexity Rises, Says Info-Tech Research Group
Atomera to Announce Second Quarter 2026 Financial Results and Host Webinar on Tuesday, August 4, 2026
Send Rakhi to UK swiftly with UK Gifts Portal
Whiteboard Series with NEAR | Ep: 45 Joel Thorstensson from ceramic.network
New Gooseneck Omni Antennas Offer Enhanced Signals in a Durable Package
Why You Should Build on #NEAR – Co-founder Illia Polosukhin at CV Labs
Whiteboard Series with NEAR | Ep: 45 Joel Thorstensson from ceramic.network
NEAR End of Year Town Hall 2021: The Open Web World, MetaBUILD 2 Hackathon and 2021 recap
Trending
-
Coin Market5 days agoBitcoin outlook improves amid 6% weekly gain: Can BTC bulls push higher?
-
Technology5 days agoTimed with the Canton Fair, Connexion ShenZhen 2026 Unveils Major Fourth-Edition Upgrades as a Greater Bay Area Mega Sourcing Event
-
Coin Market4 days agoThe British Virgin Islands are a top crypto hub no one ever talks about: Here’s why
-
Technology4 days agoGlobal Times: China sends fresh signal on global AI cooperation at WAIC
-
Coin Market5 days agoTrump teleprompter operator made $100K betting on Kalshi markets tied to speeches: ABC
-
Technology5 days agoGrand Bargain Project Announces Procedural Change that Will Turn Congress into a Problem-Solving Institution Within Days
-
Technology5 days agoDrake Expands End-to-End Professional Services with Launch of Drake Audit Defense™
-
Technology5 days agoTexas Instruments board declares third quarter 2026 quarterly dividend
